Atlas Trials

Gene Transfer Clinical Study in Crigler-Najjar Syndrome

Clinical trial NCT03223194 · TERMINATED

Trial details

NCT number
NCT03223194
Sponsor
Audentes Therapeutics
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Crigler-Najjar Syndrome
Start date
2017-09-08
Primary completion
2021-02-11
Enrollment
1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.